Neoadjuvant Chemotherapy Therapy Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Neoadjuvant Tirellizumab Combined With Chemotherapy for Early Oral Squamous Cell Carcinoma(HNC-SYSU-004)
Conditions: Oral Cancer; PD-1 Interventions: Drug: PD-1 with chemotherapy; Procedure: upright surgery Sponsors: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 14, 2023 Category: Research Source Type: clinical trials

Clinical Study of Taurine Combined With Neoadjuvant Chemo-Immunotherapy for Treatment of Locally Advanced Gastric Cancer
Conditions: Gastric Cancer Interventions: Dietary Supplement: Taurine; Biological: Serplulimab; Drug: XELOX regimen; Drug: FLOT regimen Sponsors: Tang-Du Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 13, 2023 Category: Research Source Type: clinical trials

Neoadjuvant Tislelizumab With Chemotherapy for the Treatment of MSS Colon Cancer
Conditions: Colonic Neoplasms; Neoadjuvant Therapy; Immune Checkpoint Inhibitors Interventions: Drug: Anti-PD-1 monoclonal antibody; Drug: Oxaliplatin; Drug: Capecitabine 500 MG; Procedure: Colectomy Sponsors: First Affiliated Hospital of Guangxi Medical University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 9, 2023 Category: Research Source Type: clinical trials

New Prognostic Index for Neoadjuvant Chemotherapy Outcome in Patients With Advanced High-grade Serous Ovarian Cancer
Conditions: Ovarian Cancer; Neoadjuvant Chemotherapy; Prognostic Cancer Model Interventions: Diagnostic Test: CRS scoring; Diagnostic Test: Routine blood laboratory testing before treatment Sponsors: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University Enrolling by invitation (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 7, 2023 Category: Research Source Type: clinical trials

Neoadjuvant Chemotherapy for Obstructive Colon cancER First Treated by cOlostomy
Conditions: Colon Cancer Interventions: Drug: Neoadjuvant chemotherapy Sponsors: University Hospital, Rouen Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 30, 2023 Category: Research Source Type: clinical trials

Dalpiciclib Plus AI (Neoadjuvant Endocrine Therapy) Compared With Neoadjuvant Chemotherapy in Early Breast Cancer （EBC）
Conditions: Breast Cancer Interventions: Drug: Dalpiciclib; Drug: Aromatase inhibitor; Drug: Docetaxel injection; Drug: Epirubicin Hydrochloride Injection; Drug: Cyclophosphamide injection Sponsors: Hebei Medical University Fourth Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 30, 2023 Category: Research Source Type: clinical trials

Evaluating the Efficacy and Safety of Pembrolizumab Plus Standard Chemotherapy in the Neoadjuvant Treatment of Local Advanced (LA) HNSCC
Conditions: Head and Neck Squamous Cell Carcinoma; Neoadjuvant Therapy; Pembrolizumab Interventions: Drug: Pembrolizumab; Drug: Cisplatin; Drug: Carboplatin; Drug: Nedaplatin; Drug: Nab paclitaxel; Drug: Docetaxel; Drug: Liposomal paclitaxel; Drug: Fluorouracil Sponsors: Beijing Tongren Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 26, 2023 Category: Research Source Type: clinical trials

Neoadjuvant Chemoradiotherapy Versus Total Neoadjuvant Therapy in the Treatment of T3 Rectal Cancer
Conditions: Rectal Cancer Interventions: Drug: Neoadjuvant Chemoradiotherapy; Drug: Total Neoadjuvant Therapy Sponsors: St. James ' s Hospital, Ireland Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 24, 2023 Category: Research Source Type: clinical trials

Axillary Management After Neoadjuvant Chemotherapy
Conditions: Breast Cancer; Breast Neoplasms; Breast Cancer Female Interventions: Procedure: Axillary sentinal lymph node biopsy Sponsors: Medipol University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 23, 2023 Category: Research Source Type: clinical trials

Investigate the Prognostic and Predictive Value of ctDNA During Neoadjuvant Chemotherapy for Breast Cancer.
Conditions: Breast Cancer Female; Stage II Breast Cancer; Stage III Breast Cancer; HER2-positive Breast Cancer; Triple Negative Breast Cancer Sponsors: Gene Solutions Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 17, 2023 Category: Research Source Type: clinical trials

Sentinel lympH Node Biopsy With Indocyanine Green in Breast Cancer After NEoadjuvant Chemotherapy (SHINE)
Conditions: Breast Cancer Interventions: Procedure: ICG guided sentinel lymph node biopsy Sponsors: University Health Network, Toronto Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 16, 2023 Category: Research Source Type: clinical trials

Penpulimab Combined With Chemotherapy for Neoadjuvant and Adjuvant Therapy in Patients With Resectable HNSCC
Conditions: Head and Neck Squamous Cell Carcinoma Interventions: Drug: Penpulimab injection; Drug: cisplatin; Drug: albumin-paclitaxel Sponsors: Shanghai Ninth People ' s Hospital Affiliated to Shanghai Jiao Tong University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 13, 2023 Category: Research Source Type: clinical trials

Classifying for HER2 Dependence to De-Escalate Neoadjuvant Chemotherapy in Patients With HER2+ Early Breast Cancer Undergoing HER2 Double-Blockade
Conditions: Breast Cancer; HER2-positive Breast Cancer Interventions: Drug: PHESGO Sponsors: Latin American Cooperative Oncology Group; Roche Pharma AG; Oncocl ínicas Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 5, 2023 Category: Research Source Type: clinical trials

Risk Factors of Relapse in Esophageal Squamous Cell Cancers Who Achieve PCR to Neoadjuvant Chemoradiotherapy
Conditions: Esophageal Cancer Interventions: Other: follow up Sponsors: Sun Yat-sen University Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 29, 2023 Category: Research Source Type: clinical trials

Neoadjuvant Chemoradiotherapy Combined With PD-1 Inhibitor and Thymalfasin for pMMR/MSS Locally Advanced Mid-low Rectal Cancer
Condition: Locally Advanced Rectal Cancer Interventions: Drug: capecitabine; Drug: tislelizumab; Drug: thymalfasin; Radiation: long-term radiotherapy Sponsors: Beijing Friendship Hospital; Peking Union Medical College Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 27, 2023 Category: Research Source Type: clinical trials